Traduction de «etridiazole » (Anglais → Français) :

ethyl 3-trichloromethyl-1,2,4-thiadiazol-5-yl ether [ etridiazole ]

5-ethoxy-3-(trichloromethyl)-1,2,4-thiadiazole | ethyl 3-trichloromethyl-1,2,4-thiadiazol-5-yl ether | etridiazole

Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for Bacillus amyloliquefaciens strain FZB24, Bacillus amyloliquefaciens strain MBI 600, clayed charcoal, dichlorprop-P, ethephon, etridiazole, flonicamid, fluazifop-P, hydrogen peroxide, metaldehyde, penconazole, spinetoram, tau-fluvalinate and Urtica spp. in or on certain products (D051407/02 — 2017/2786(RPS) — deadline: 15 September 2017)

Moreover, it is appropriate to require that the applicant submit further information confirming: the specification of the technical material as commercially manufactured by appropriate analytical data, the relevance of the impurities, the equivalence between the specifications of the technical material, as commercially manufactured, and those of the test material used in the ecotoxicity dossiers, the relevance of the plant metabolites 5-hydroxy-ethoxyetridiazole acid and 3-hydroxymethyletridiazole, the indirect exposure of groundwater and soil-dwelling organisms to etridiazole and to its soil metabolites dichloro-etridiazole and etridiaz ...[+++]ole acid, and the long-range and short-range transport through the atmosphere of etridiazole acid.

indirect exposure of groundwater and soil-dwelling organisms to etridiazole and to its soil metabolites dichloro-etridiazole and etridiazole acid;

2. By way of derogation from paragraph 1, for each authorised plant protection product containing etridiazole as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 May 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning etridiazole. On the basis of that evaluation, they shall determin ...[+++]e whether the product satisfies the conditions set out in Article 4(1)(b), (c), (d) and (e) of Directive 91/414/EEC.